A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

NCT06518408 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

287

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Cabotegravir Injectable Product
DRUG: Rilpivirine Injectable Product

Sponsor

University Hospital Virgen de las Nieves

Collaborators

[object Object]